Login / Signup
Sedat Gulten
(Sedat Gülten)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Peritoneal Dialysis
Coronavirus Disease
Patient Reported Outcomes
Rheumatoid Arthritis Patients
Top Venues
Diagnostics (Basel, Switzerland)
Revista da Associacao Medica Brasileira (1992)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Idris Kocaturk
,
Sedat Gulten
,
Bunyamin Ece
,
Fatma Mutlu Kukul Guven
Exploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies.
Diagnostics (Basel, Switzerland)
14 (6) (2024)
Idris Kocaturk
,
Sedat Gulten
,
Bunyamin Ece
,
Fatma Mutlu Kukul Guven
Exploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies.
Diagnostics (Basel, Switzerland)
14 (6) (2024)
Idris Kocaturk
,
Sedat Gulten
,
Bunyamin Ece
,
Fatma Mutlu Kukul Guven
Exploring PGE2 and LXA4 Levels in Migraine Patients: The Potential of LXA4-Based Therapies.
Diagnostics (Basel, Switzerland)
14 (6) (2024)
Muhammet Gülhan
,
Uğur Önal
,
Neşe Demirci
,
Gulcan Cetin
,
Abdullah Calisir
,
Damla Köksalan
,
Kübra Solmaz
,
Ayhan Kars
,
Çetin Kılınç
,
Sedat Gulten
Tocilizumab is useful for coronavirus disease 2019 patients: the key point is timing.
Revista da Associacao Medica Brasileira (1992)
68 (3) (2022)